Ionis Pharmaceuticals (IONS) Minority Interest (2009 - 2020)

Ionis Pharmaceuticals' Minority Interest history runs 5 years deep, the most recent figure standing at $223.2 million for Q3 2020.

• On a quarterly basis, Minority Interest rose 38.08% year-over-year to $223.2 million in Q3 2020; TTM through Sep 2020 was $223.2 million, a 38.08% increase from a year earlier, with the FY2019 full-year figure at $213.5 million, up 53.47% from the prior year.
• Minority Interest grew to $223.2 million in Q3 2020 per IONS's latest filing, from $217.6 million in the prior quarter.
• Across five years, Minority Interest topped out at $223.2 million in Q3 2020 and bottomed at $84.3 million in Q4 2017.
• The 4-year median for Minority Interest is $161.7 million (2019), against an average of $157.2 million.
• Across the five-year window, Minority Interest soared 109.74% in 2019 and grew 15.87% in 2020, its largest moves.
• Year by year, Minority Interest stood at $84.3 million in 2017, then soared by 65.05% to $139.1 million in 2018, then surged by 53.47% to $213.5 million in 2019, then increased by 4.58% to $223.2 million in 2020.
• Per Business Quant, the three latest IONS Minority Interest figures stand at $223.2 million (Q3 2020), $217.6 million (Q2 2020), and $210.2 million (Q1 2020).